You are here

Immunocore

Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Pharma Voice

Thu, 02/20/25 - 11:35 am

Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D

Endpoints

Mon, 07/18/22 - 07:13 pm

Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers

BioSpace

Sun, 06/5/22 - 11:31 pm

clinical trials

2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

Motley Fool

Wed, 04/6/22 - 12:24 pm

TCR immunotherapy

Immunocore soars 17% as FDA approves Kimmtrak for uveal melanoma

Seeking Alpha

Wed, 01/26/22 - 10:53 am

ESMO 2021 movers – a handful of biotech winners emerge

EP Vantage

Fri, 09/24/21 - 11:48 am

Corbus Pharmaceuticals

Leap Therapeutics

Surface Oncology

Spectrum Pharrmaceuticals

Mirati Therapeutics

GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out

Fierce Biotech

Wed, 04/28/21 - 10:47 am

Duchenne Muscular Dystrophy

Immunocore gets FDA breakthrough nod for eye melanoma drug ahead of planned Q3 filing

Fierce Biotech

Fri, 02/19/21 - 10:28 am

breakthrough therapy

Immunocore IPO filing reveals kickback scheme, Immatics row and phishing attacks

Fierce Biotech

Tue, 01/26/21 - 11:32 am

IPO tracker: 2021 gets started with a flurry of new offerings

Endpoints

Mon, 01/25/21 - 10:43 am

Sana Biotechnology

Sensei Biotherapeutics

Bolt Biotherapeutics

Terns Pharmaceuticals

Gracell Biotechnologies

Cullinan Oncology

Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK

Endpoints

Mon, 01/11/21 - 10:38 am

clinical trials

Immunocore raises $130M to fund pivotal cancer program

Fierce Biotech

Mon, 03/2/20 - 10:11 am

Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug

Fierce Biotech

Mon, 11/19/18 - 09:54 am

Amid Immunocore’s C-suite bloodletting Glaxo provides solace

EP Vantage

Mon, 08/20/18 - 11:01 pm

clinical trials

Immunocore to Accelerate Cancer Program With $320 Million Raised

Bloomberg

Thu, 07/16/15 - 10:24 pm

Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally

Fierce Biotech

Thu, 07/2/15 - 11:12 am

Cell Therapy Group

Eli Lilly joins forces with UK biotech to develop cancer drugs

FT.com

Wed, 07/16/14 - 10:39 am

AstraZeneca raises bet on cancer immunotherapy with Immunocore deal

Yahoo/Reuters

Wed, 01/8/14 - 08:09 am

FierceBiotech's 2013 Fierce 15

Fierce Biotech

Wed, 09/25/13 - 01:04 pm

Acetylon Pharmaceuticals

Jounce Therapeutics

Kala Pharmaceuticals

Moderna Therapeutics

Presage Biosciences

Nimbus Discovery

GSK taps UK firm for "beyond antibodies" drug technology

Reuters

Tue, 07/9/13 - 10:09 am

Pages